Impedimed Ltd (OTCPK:IPDQF)
$ 0.0421 0 (0%) Market Cap: 72.33 Mil Enterprise Value: 57.27 Mil PE Ratio: 0 PB Ratio: 4.21 GF Score: 0/100

Q1 2020 ImpediMed Ltd Earnings Call Transcript

Oct 29, 2019 / 10:15PM GMT
Release Date Price: $0.1
Operator

Thank you for standing by, and welcome to the ImpediMed quarterly results investor call. (Operator Instructions)

I would now like to hand the conference over to Mr. Rick Carreon, Managing Director and CEO. Please go ahead.

Richard Carreon
ImpediMed Limited - MD, CEO, President & Executive Director

Thank you, Chantel, and welcome, everyone. Thank you for joining us today. We're hosting this conference call to discuss our 4C for the financial year quarter ending 30 September 2019. Our Vice President of Finance, Mr. Tim Cruickshank, will be filling in for Morten Vigeland, our CFO, who is unavailable for today's call.

During our call today, I'll be referencing the 4C we launched earlier this morning in Australian time. As we normally do, I'll take questions following my comments.

This quarter marks a key inflection point for ImpediMed. First of all, Software-as-a-Service became the key revenue and growth generator for the company, and recall, this is a business that is less than 2 years old. Two, we launched the lymphedema

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot